The Trulicity pen -- an injectable drug for patients to manage their type 2 diabetes -- has been around for quite some time. According to Drugs.com, the medication was first approved by the U.S. Food ...

New phase 3b trial results show Lilly’s Trulicity has helped type 2 diabetes patients already taking an SGLT2 inhibitor but whose blood sugar was inadequately controlled. The AWARD trial showed ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

However, Eli Lily is a fast-growing company, with a price/earnings-to-growth ratio (PEG ratio) of only 0.5. PEGs under 1 are ...

Eli Lilly LLY will report its third-quarter 2024 earnings on Oct. 30, before market open. The Zacks Consensus Estimate for ...

Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...

The pharmaceutical giant is expected to garner $12.1 billion in sales and $1.45 in adjusted earnings per share, per the ...

I insisted on a replacement medicine, and he prescribed Trulicity. The cost was terribly high. The first three months was realistic, then I went into the donut hole. Should people like me just ...

Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two ...

Some GLP-1s, like Ozempic (semaglutide), tirzepatide (Mounjaro), and dulaglutide (Trulicity), are usually taken weekly. Others, like liraglutide (Saxenda, Victoza), are typically administered daily.

David J. Phillip/AP The list includes medications for type 2 diabetes, allergic diseases, chronic kidney disease, heart ...

GLP-1 receptor agonists and SGLT2 inhibitors were both initially approved for type 2 diabetes. But over the last several ...